Welcome to our dedicated page for Inogen news (Ticker: INGN), a resource for investors and traders seeking the latest updates and insights on Inogen stock.
News for Inogen Inc (INGN) centers on its activities as a medical technology company focused on respiratory products for homecare use. This page aggregates company press releases, earnings announcements, product launches, and other public updates that Inogen provides to investors, patients, and partners.
Inogen regularly issues quarterly financial results and outlook updates, detailing revenue by sales and rental categories, business-to-business and direct-to-consumer performance, gross margin trends, operating expenses, and non-GAAP measures such as EBITDA and adjusted EBITDA. These releases often highlight factors driving performance, such as demand from domestic and international business-to-business customers and changes in direct-to-consumer and rental revenue.
Product-related news is another key theme. Recent announcements include the launch of the Voxi 5 stationary oxygen concentrator, designed to expand access to oxygen therapy for long-term care patients in the United States, and the introduction of Aurora CPAP masks for patients with obstructive sleep apnea. Such updates illustrate how Inogen is broadening its respiratory care portfolio beyond portable oxygen concentrators into stationary oxygen therapy and sleep-therapy accessories.
Corporate and leadership developments, such as technology and executive appointments, also appear in Inogen’s news flow, offering context on how the company is organizing around digital health, connected devices, and operational execution. Investors and observers can use this news page to follow Inogen’s financial trajectory, portfolio evolution, and strategic priorities in home respiratory and sleep care.
For anyone tracking INGN stock, revisiting this page provides a consolidated view of Inogen’s latest earnings releases, conference call announcements, and product milestones, all drawn from the company’s own public communications.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Inogen, Inc. (Nasdaq: INGN) is set to announce its first quarter 2023 financial results after market close on May 4, 2023. The company will host a conference call on the same day at 2:00 p.m. PT / 5:00 p.m. ET. Investors can access the call by dialing (888) 645-4404 for US callers and (862) 298-0702 for international callers. A live webcast will also be available on Inogen’s Investor Relations website at http://investor.inogen.com/, which will be archived for six months. A replay of the call will be accessible starting three hours post-call until May 11, 2023.
Inogen, Inc. (Nasdaq: INGN) announced its participation in the 22nd Annual Needham Virtual Healthcare Conference on April 19, 2023, at 12:45 p.m. ET. The event will include a live audio webcast and an archived recording accessible via the News / Events section of Inogen's Investor Relations website. As a leader in the medical technology sector, Inogen specializes in innovative respiratory products for homecare settings, focusing on portable oxygen concentrators for chronic respiratory conditions. For more details, visit www.inogen.com.
Inogen, Inc. has appointed Tom West to its Board of Directors, effective April 1, 2023, while Kristen Miranda will retire on March 31, 2023. Tom West brings extensive experience from various leadership roles in the medical technology sector, including his recent position as CEO of Intersect ENT, Inc.. The Board's chair, Elizabeth Mora, emphasizes West's potential to enhance Inogen's strategic initiatives and operational efficiency. West expressed enthusiasm for driving growth at Inogen, which specializes in respiratory care products. This change is part of the company's efforts to strengthen its leadership amidst ongoing transformation.
Inogen, a medical technology company focused on innovative respiratory products, will participate in a virtual fireside chat at the KeyBanc Virtual Life Sciences & MedTech Investor Forum on March 21, 2023, at 2:15 p.m. Eastern Time. The chat aims to enhance engagement with investors and provide insights into Inogen's operations. A live audio webcast and an archived recording will be accessible through the company's Investor Relations website. Inogen specializes in portable oxygen concentrators, supporting patients with chronic respiratory conditions.